| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0001675> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0003250> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0003451> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0010992> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0036859> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0085415> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0086287> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0086582> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0087113> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0238598> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0521117> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C0600378> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C3850123> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C4704925> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C5203676> <https://research.tib.eu/covid-19/entity/34346827_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'Shanghai Public Health Clinical Center, Fudan University, Shanghai, People\'s Republic of China.\', \'Mabwell (Shanghai) Bioscience Co., Ltd., Shanghai, People\'s Republic of China.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Li_Ruowan> <https://research.tib.eu/covid-19/entity/Lin_Xiaoyan> <https://research.tib.eu/covid-19/entity/Liu_Datao> <https://research.tib.eu/covid-19/entity/Liu_Jing> <https://research.tib.eu/covid-19/entity/Lu_Hongzhou> <https://research.tib.eu/covid-19/entity/Lu_Song> <https://research.tib.eu/covid-19/entity/Lu_Yan> <https://research.tib.eu/covid-19/entity/Meng_Xianmin> <https://research.tib.eu/covid-19/entity/Wang_Peipei> <https://research.tib.eu/covid-19/entity/Wang_Shuhai> <https://research.tib.eu/covid-19/entity/Wu_Yan> <https://research.tib.eu/covid-19/entity/Wu_Yijun> <https://research.tib.eu/covid-19/entity/Xiong_Yanqing> <https://research.tib.eu/covid-19/entity/Zeng_Liyan> <https://research.tib.eu/covid-19/entity/Zeng_Shaoqing> <https://research.tib.eu/covid-19/entity/Zhang_Jinchao> <https://research.tib.eu/covid-19/entity/Zhao_Bei>
?:doi	10.1080/22221751.2021.1960900
?:doi	<https://research.tib.eu/covid-19/entity/10.1080/22221751.2021.1960900>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Clinical_Trial%2C_Phase_I> <https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Randomized_Controlled_Trial>
?:journal	Emerging microbes & infections
is ?:pmid of	<https://research.tib.eu/covid-19/entity/34346827>
?:pmid	<https://research.tib.eu/covid-19/entity/34346827>
?:pmid	34346827
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/C1708335_LOCATION_OF_C3811629>
?:title	Safety, tolerability, pharmacokinetic characteristics, and immunogenicity of MW33: a Phase 1 clinical study of the SARS-CoV-2 RBD-targeting monoclonal antibody.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/34346827>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/34346827>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all